Is blood eosinophilia a treatable trait in chronic obstructive airway diseases? - PubMed
3 hours ago
- #Asthma
- #COPD
- #Eosinophilia
- Blood eosinophilia serves as a biomarker for type 2 inflammation in asthma and COPD, though its role as a diagnostic and therapeutic target is debated.
- A clinical case illustrates a shift from severe COPD to severe eosinophilic asthma, leading to treatment with mepolizumab and excellent clinical response despite no lung function improvement.
- Eosinophilic inflammation is common in asthma, but a subset of COPD patients exhibit it, making blood eosinophilia a potential treatable trait when integrated into a multidimensional assessment.